There are novel biomarkers showing predictive value for AKI, including cystatin C, neutrophil gelatinase-associated lipocalin, interleukin-18, protein C, insulin-like growth factor-binding protein 7, tissue inhibitor of metalloproteinases-2, and kidney injury molecule-1. This evidence concerns the gene LCN2 and acute kidney injury.